{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:58:40Z","timestamp":1791644320414,"version":"4.3.4"},"reference-count":283,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Gda\u0144sk Medical University","doi-asserted-by":"publisher","award":["01-62025\/0008403\/643"],"award-info":[{"award-number":["01-62025\/0008403\/643"]}],"id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Compounds based on an isoquinoline scaffold (benzo[c]pyridine) display a broad spectrum of biological activities. In recent years, studies have focused mainly on their anticancer properties. Their antiproliferative effects are associated with diverse mechanisms that include targeting PI3K\/Akt\/mTOR signaling pathways and reactive oxygen species or inducing apoptosis and cell cycle arrest. Furthermore, isoquinolines may inhibit microtubule polymerization, topoisomerase, or tumor multidrug resistance. Recent studies have also shown that these compounds may act as effective antimicrobial, antifungal, antiviral, and antiprotozoal agents. Moreover, it has also been demonstrated that isoquinoline derivatives exhibit potent anti-Alzheimer effects, alleviating central nervous system functions. Additionally, they possess anti-inflammatory and antidiabetic properties. Due to the presence of donor nitrogen, the isoquinoline core constitutes an appropriate ligand that may be employed for the development of metal complexes with improved pharmacological properties. A number of chelates containing copper, iridium, or platinum were found to exhibit prominent biological activity, which places them in a leading position for the development of effective medications. This review summarizes the recent development of synthetic isoquinoline-based compounds with proven pharmacological properties in the period of 2020\u20132025. Also, other biomedical applications for synthetic isoquinoline derivatives are provided.<\/jats:p>","DOI":"10.3390\/molecules30244760","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T14:04:40Z","timestamp":1765548280000},"page":"4760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recent Advances in Synthetic Isoquinoline-Based Derivatives in Drug Design"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5234-1198","authenticated-orcid":false,"given":"\u0141ukasz","family":"Balewski","sequence":"first","affiliation":[{"name":"Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gda\u0144sk, 80-416 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2792-9229","authenticated-orcid":false,"given":"Anita","family":"Kornicka","sequence":"additional","affiliation":[{"name":"Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gda\u0144sk, 80-416 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12551-015-0183-5","article-title":"Natural isoquinoline alkaloids: Binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme","volume":"7","author":"Khan","year":"2015","journal-title":"Biophys. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115704","DOI":"10.1016\/j.biopha.2023.115704","article-title":"New trends in the practical use of isoquinoline alkaloids as potential drugs applicated in infectious and non-infectious diseases","volume":"168","author":"Tuzimski","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1039\/D4NP00023D","article-title":"Isolation, biological activity, and synthesis of isoquinoline alkaloids","volume":"41","author":"Yang","year":"2024","journal-title":"Nat. Prod. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Yun, D., Yoon, S.Y., Park, S.J., and Park, Y.J. (2021). The anticancer effect of natural plant alkaloid isoquinolines. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041653"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.2174\/1381612824666180829100601","article-title":"The anticancer effect of sanguinarine: A review","volume":"24","author":"Fu","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4155\/fmc-2017-0041","article-title":"Anticancer potential of sanguinarine for various human malignancies","volume":"9","author":"Achkar","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/1871520622666220804115551","article-title":"Insight into the tubulin-targeted anticancer potential of noscapine and its structural analogs","volume":"23","author":"Kumar","year":"2023","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.2174\/1871520621666210126091512","article-title":"Sanguinarine: A double-edged sword of anticancer and carcinogenesis and its future application prospect","volume":"21","author":"Lou","year":"2021","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.2174\/0929867324666170920125135","article-title":"Anticancer and reversing multidrug resistance activities of natural isoquinoline alkaloids and their structure-activity relationship","volume":"25","author":"Qing","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2174\/1568026621666210526164208","article-title":"The recent development of tetrahydro-quinoline\/isoquinoline based compounds as anticancer agents","volume":"21","author":"Yadav","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bhambhani, S., Kondhare, K.R., and Giri, A.P. (2021). Diversity in chemical structures and biological properties of plant alkaloids. Molecules, 26.","DOI":"10.3390\/molecules26113374"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.orglett.9b00778","article-title":"Diverse isoquinoline scaffolds by Ugi\/Pomeranz\u2013Fritsch and Ugi\/Schlittler\u2013M\u00fcller reactions","volume":"21","author":"Wang","year":"2019","journal-title":"Org. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/ndt\/gfab191","article-title":"Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomized, open-label, active-controlled study (DOLOMITES)","volume":"36","author":"Barratt","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhu, X., Jiang, L., Wei, X., Long, M., and Du, Y. (2022). Roxadustat: Not just for anemia. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.971795"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40262-015-0299-6","article-title":"Asunaprevir: A review of preclinical and clinical pharmacokinetics and drug\u2013drug interactions","volume":"54","author":"Eley","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"132576","DOI":"10.1016\/j.tet.2021.132576","article-title":"A review of the synthesis of 1,2-dihydroisoquinoline, [2,1-a] isoquinoline and [5,1-a] isoquinoline since 2006","volume":"104","author":"Hajinasiri","year":"2022","journal-title":"Tetrahedron"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1023\/A:1016045103414","article-title":"Three-component synthesis of 3,4-dihydroisoquinoline derivatives","volume":"51","author":"Shklyaev","year":"2002","journal-title":"Russ. Chem. Bull."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yoshida, M., Imaji, R., and Shiomi, S. (2024). Synthesis of substituted 1,2-dihydroisoquinolines by palladium-catalyzed cascade cyclization-coupling of trisubstituted allenamides with arylboronic acids. Molecules, 29.","DOI":"10.20944\/preprints202406.0488.v1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100561","DOI":"10.1016\/j.cogsc.2021.100561","article-title":"Microbial synthesis of natural, semisynthetic, and new-to-nature tetrahydroisoquinoline alkaloids","volume":"33","author":"Pyne","year":"2022","journal-title":"Curr. Opin. Green Sustain. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/17460441.2021.1916464","article-title":"1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design","volume":"16","author":"Faheem","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13543776.2017.1236084","article-title":"Tetrahydroisoquinolines in therapeutics: A patent review (2010\u20132015)","volume":"27","author":"Singh","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/13543776.2024.2391288","article-title":"Tetrahydroisoquinolines\u2014An updated patent review for cancer treatment (2016\u2013present)","volume":"34","author":"Tanwar","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1021\/acs.chemrev.3c00054","article-title":"Recent advances in the total synthesis of the tetrahydroisoquinoline alkaloids (2002\u20132020)","volume":"123","author":"Kim","year":"2023","journal-title":"Chem. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1021\/acs.accounts.4c00262","article-title":"Evolution of a synthetic strategy toward the syntheses of bis-tetrahydroisoquinoline alkaloids","volume":"57","author":"Ngamnithiporn","year":"2024","journal-title":"Acc. Chem. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14740338.2023.2203481","article-title":"Benefit and risk evaluation of quinapril hydrochloride","volume":"22","author":"Barkhordarian","year":"2023","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_27","first-page":"23","article-title":"Moexipril and left ventricular hypertrophy","volume":"3","author":"Chrysant","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.116.237271","article-title":"Potential L-type voltage-operated calcium channel blocking effect of drotaverine on functional models","volume":"359","author":"Patai","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200948050-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of solifenacin","volume":"48","author":"Doroshyenko","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1021\/ja01188a001","article-title":"Preparation of cis- and trans-decahydroisoquinolines and of bz-tetrahydroisoquinoline","volume":"70","author":"Witkop","year":"1948","journal-title":"J. Am. Chem. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jps.2600610435","article-title":"Steric and physicochemical studies of decahydroisoquinolines possessing antiarrhythmic activity","volume":"61","author":"Mathison","year":"1972","journal-title":"J. Pharm. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0028-3908(98)00134-8","article-title":"Decahydroisoquinolines: Novel competitive AMPA\/kainate antagonists with neuroprotective effects in global cerebral ischaemia","volume":"37","author":"Bond","year":"1998","journal-title":"Neuropharmacology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Gomes, D.A., Joubert, A.M., and Visagie, M.H. (2022). The biological relevance of papaverine in cancer cells. Cells, 11.","DOI":"10.3390\/cells11213385"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ddr.22022","article-title":"A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer","volume":"84","author":"Orujova","year":"2023","journal-title":"Drug Dev. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tang, X., Yan, Z., Miao, Y., Ha, W., Li, Z., Yang, L., and Mi, D. (2023). Copper in cancer: From limiting nutrient to therapeutic target. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1209156"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00432-024-05641-5","article-title":"Unveiling the promising anticancer effect of copper-based compounds: A comprehensive review","volume":"150","author":"Abdolmaleki","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/cac2.70005","article-title":"Copper in cancer: Friend or foe? Metabolism, dysregulation, and therapeutic opportunities","volume":"45","author":"Shan","year":"2025","journal-title":"Cancer Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1039\/C9MD00594C","article-title":"Isoquinoline thiosemicarbazone displays potent anticancer activity with in vivo efficacy against aggressive leukemias","volume":"11","author":"Sun","year":"2020","journal-title":"RSC Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"129710","DOI":"10.1016\/j.bmcl.2024.129710","article-title":"Design, synthesis, and biological evaluation of novel benzo[6,7]indolo [3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition","volume":"104","author":"Sakai","year":"2024","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zheng, B., Wang, Y.X., Wu, Z.Y., Li, X.W., Qin, L.Q., Chen, N.Y., Su, G.F., Su, J.C., and Pan, C.X. (2025). Design, synthesis and bioactive evaluation of Topo I\/c-MYC dual inhibitors to inhibit oral cancer via regulating the PI3K\/AKT\/NF-\u03baB signaling pathway. Molecules, 30.","DOI":"10.3390\/molecules30040894"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1039\/C9OB02441G","article-title":"Isoquinolinequinone N-oxides as anticancer agents effective against drug resistant cell lines","volume":"18","author":"Kruschel","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"119470","DOI":"10.1016\/j.lfs.2021.119470","article-title":"Selective AMPK activator leads to unfolded protein response downregulation and induces breast cancer cell death and autophagy","volume":"276","author":"Sagrillo","year":"2021","journal-title":"Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2129884","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: A review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Investig. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","article-title":"Barriers and opportunities for gemcitabine in pancreatic cancer therapy","volume":"324","author":"Beutel","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/jso.27462","article-title":"Global trends in the incidence and mortality of pancreatic cancer based on geographic location, socioeconomic status, and demographic shift","volume":"128","author":"Sharma","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"117443","DOI":"10.1016\/j.envres.2023.117443","article-title":"Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug\/nanotherapeutic approaches","volume":"240","author":"Ashrafizadeh","year":"2024","journal-title":"Environ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"28916","DOI":"10.1039\/D2RA05758A","article-title":"Naphthylisoindolinone alkaloids: The first ring-contracted naphthylisoquinolines, from the tropical liana Ancistrocladus abbreviatus, with cytotoxic activity","volume":"12","author":"Fayez","year":"2022","journal-title":"RSC Adv."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1039\/D1NP00020A","article-title":"N,C-coupled naphthylisoquinoline alkaloids: A versatile new class of axially chiral natural products","volume":"38","author":"Tajuddeen","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/acschembio.4c00870","article-title":"Toyaburgine, a synthetic N-biphenyl-dihydroisoquinoline inspired by related N,C-coupled naphthylisoquinoline alkaloids, with high in vivo efficacy in preclinical pancreatic cancer models","volume":"20","author":"Awale","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ma, L., Bian, M., Gao, H., Zhou, Z., and Yi, W. (2022). A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancer. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268060"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Al-Matarneh, M.C., Am\u0103randi, R.M., Mangalagiu, I.I., and Danac, R. (2021). Synthesis and biological screening of new cyano-substituted pyrrole fused (iso)quinoline derivatives. Molecules, 26.","DOI":"10.3390\/molecules26072066"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e007798","DOI":"10.1136\/jitc-2023-007798","article-title":"Neuroblastoma: An ongoing cold front for cancer immunotherapy","volume":"11","author":"Kennedy","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpam.2021.02.006","article-title":"Pediatric high risk neuroblastoma with autologous stem cell transplant\u201420 years of experience","volume":"8","author":"Khan","year":"2021","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1093\/neuonc\/noae152","article-title":"Defining neuroblastoma: From origin to precision medicine","volume":"26","author":"Santopolo","year":"2024","journal-title":"Neuro-Oncology"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Tber, Z., Loubidi, M., Jouha, J., Hdoufane, I., Erdogan, M.A., Saso, L., Armagan, G., and Berteina-Raboin, S. (2021). Pyrido[2\u2032,1\u2032:2,3]imidazo[4,5-c]isoquinolin-5-amines as potential cytotoxic agents against human neuroblastoma. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080750"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"107831","DOI":"10.1016\/j.bioorg.2024.107831","article-title":"Synthesis and modification of noscapine derivatives as promising future anticancer agents","volume":"153","author":"Nemati","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10822-025-00617-0","article-title":"N-imidazopyridine derivatives of noscapine as potent tubulin-binding anticancer agents: Chemical synthesis and cellular evaluation","volume":"39","author":"Dash","year":"2025","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine\u2014A molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"104694","DOI":"10.1016\/j.bioorg.2021.104694","article-title":"Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives","volume":"109","author":"Gao","year":"2021","journal-title":"Bioorganic Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.ejmech.2017.11.007","article-title":"Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity","volume":"143","author":"Lan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2017.01.008","article-title":"Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma","volume":"127","author":"Lan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1080\/10286020.2016.1188085","article-title":"Design and synthesis of new tetrandrine derivatives and their antitumor activities","volume":"18","author":"Wei","year":"2016","journal-title":"J. Asian Nat. Prod. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1039\/C8MD00125A","article-title":"Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents","volume":"9","author":"Song","year":"2018","journal-title":"Med. Chem. Comm."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bmcl.2016.12.029","article-title":"Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents","volume":"27","author":"Li","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"112810","DOI":"10.1016\/j.ejmech.2020.112810","article-title":"Synthesis, biological evaluation and toxicity of novel tetrandrine analogues","volume":"207","author":"Geisslinger","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_69","first-page":"7433","article-title":"Tetrandrine suppresses lung cancer growth and induces apoptosis, potentially via the VEGF\/HIF-1\u03b1\/ICAM-1 signaling pathway","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"151769","DOI":"10.1016\/j.acthis.2021.151769","article-title":"The enhancement of tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K\/Akt\/mTOR-mediated apoptosis and AMPK-regulated autophagy","volume":"123","author":"Song","year":"2021","journal-title":"Acta Histochem."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wang, Y.C., Zhang, R., Hu, S.C., Zhang, H., Yang, D., Zhang, W.L., Zhao, Y.L., Cui, D.B., Li, Y.J., and Pan, W.D. (2022). Design, synthesis, and biological evaluation of N14-amino acid-substituted tetrandrine derivatives as potential antitumor agents against human colorectal cancer. Molecules, 27.","DOI":"10.3390\/molecules27134040"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Hu, S.C., Yang, J., Chen, C., Song, J.R., and Pan, W.D. (2020). Design, synthesis of novel Tetrandrine-14-l-amino acid and tetrandrine-14-l-amino acid-urea derivatives as potential anti-cancer agents. Molecules, 25.","DOI":"10.3390\/molecules25071738"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"107069","DOI":"10.1016\/j.bioorg.2023.107069","article-title":"Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K\/AKT\/mTOR pathway","volume":"143","author":"Ling","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1039\/D1RA01480C","article-title":"Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs\u2014Biological activities and SAR studies","volume":"11","author":"Faheem","year":"2021","journal-title":"RSC Adv."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Jin, Y., Chen, F., Long, Y., Luo, J., Guo, S., Wang, L., and Chen, W. (2025). Design, synthesis, and mechanism study of novel isoquinoline derivatives containing an oxime moiety as antifungal agents. Mol. Divers.","DOI":"10.1007\/s11030-025-11317-0"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"153588","DOI":"10.1016\/j.tox.2023.153588","article-title":"Biological response and cell death signaling pathways modulated by tetrahydroisoquinoline-based  aldoximes in human cells","volume":"494","author":"Zandona","year":"2023","journal-title":"Toxicology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/01480545.2025.2491534","article-title":"Assessment of cytotoxic properties of tetrahydroisoquinoline oximes in breast, prostate and glioblastoma cancer cells","volume":"48","author":"Zandona","year":"2025","journal-title":"Drug Chem. Toxicol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-319-91442-8_4","article-title":"Crizotinib","volume":"211","author":"Heigener","year":"2018","journal-title":"Small Molecules in Oncology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2146\/ajhp120261","article-title":"Crizotinib for the treatment of non-small-cell lung cancer","volume":"70","author":"Timm","year":"2013","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cllc.2014.09.011","article-title":"Ceritinib (LDK378): A potent alternative to crizotinib for ALK-rearranged non\u2013small-cell lung cancer","volume":"16","author":"Li","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bmc.2015.12.004","article-title":"Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors","volume":"24","author":"Achary","year":"2016","journal-title":"Bioorganic Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/cbdd.14134","article-title":"Design, synthesis, and biological evaluation of tetrahydroisoquinoline stilbene derivatives as potential antitumor candidates","volume":"101","author":"Li","year":"2023","journal-title":"Chem. Biol. Drug"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"116371","DOI":"10.1016\/j.bmc.2021.116371","article-title":"Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-\u03baB signaling pathway","volume":"46","author":"Sim","year":"2021","journal-title":"Bioorganic Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1039\/D3MD00612C","article-title":"Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp\/ABCB1) inhibitors for reversing multidrug resistance","volume":"15","author":"Cao","year":"2023","journal-title":"RSC Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"116943","DOI":"10.1016\/j.ejmech.2024.116943","article-title":"Discovery of novel third generation P-glycoprotein inhibitors bearing an azo moiety with MDR-reversing effect","volume":"280","author":"Zeng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kono, Y., Kawahara, I., Shinozaki, K., Nomura, I., Marutani, H., Yamamoto, A., and Fujita, T. (2021). Characterization of P-glycoprotein inhibitors for evaluating the effect of P-glycoprotein on the intestinal absorption of drugs. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030388"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"117944","DOI":"10.1016\/j.bmc.2024.117944","article-title":"Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1\/CYP1B1 inhibitors for overcoming MDR in cancer","volume":"114","author":"Dong","year":"2024","journal-title":"Bioorganic Med. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1021\/acs.jmedchem.5b01973","article-title":"Isoquinoline-1,3-diones as selective inhibitors of tyrosyl DNA phosphodiesterase II (TDP2)","volume":"59","author":"Kankanala","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00044-020-02662-w","article-title":"4-Benzylideneisoquinoline-1,3(2H,4H)-diones as tyrosyl DNA phosphodiesterase 2 (TDP2) inhibitors","volume":"30","author":"Senaweera","year":"2021","journal-title":"Med. Chem. Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Sayed, E.M., Bakhite, E.A., Hassanien, R., Farhan, N., Aly, H.F., Morsy, S.G., and Hassan, N.A. (2024). Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: Synthesis, characterization, anticancer activity and antioxidant properties. BMC Chem., 18.","DOI":"10.1186\/s13065-024-01139-w"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Bakhite, E.A., Hassanien, R., Farhan, N., Sayed, E.M., and Sharaky, M. (2025). New tetrahydroisoquinolines bearing nitrophenyl group targeting HSP90 and RET enzymes: Synthesis, characterization and biological evaluation. BMC Chem., 19.","DOI":"10.1186\/s13065-025-01399-0"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e202402758","DOI":"10.1002\/cbdv.202402758","article-title":"New 5,6,7,8-tetrahydro-isoquinolines bearing 2-nitrophenyl group targeting RET enzyme: Synthesis, anticancer activity, apoptotic induction and cell cycle arrest","volume":"22","author":"Saddik","year":"2025","journal-title":"Chem. Biodivers."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1039\/D3RA07047F","article-title":"Pyrrolo[2,1-a]isoquinoline scaffolds for developing anti-cancer agents","volume":"14","author":"Salgado","year":"2024","journal-title":"RSC Adv."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.4155\/fmc-2019-0136","article-title":"Pyrrolo[2,1-a]isoquinoline scaffold in drug discovery: Advances in synthesis and medicinal chemistry","volume":"11","author":"Matveeva","year":"2019","journal-title":"Future Med. Chem."},{"key":"ref_95","first-page":"79","article-title":"The pyrrolo[2,1-a]isoquinoline alkaloids","volume":"70","year":"2011","journal-title":"The Alkaloids: Chemistry and Biology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1039\/D2OB00209D","article-title":"Recent progress in the synthesis of pyrrolo[2,1-a]isoquinolines","volume":"20","author":"Cui","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1248\/cpb.c17-00409","article-title":"5,6-dihydropyrrolo[2,1-a]isoquinolines as alternative of new drugs with cytotoxic activity","volume":"65","year":"2017","journal-title":"Chem. Pharm. Bull."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cmdc.201800177","article-title":"A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells","volume":"13","author":"Nevskaya","year":"2018","journal-title":"ChemMedChem"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Nevskaya, A.A., Purgatorio, R., Borisova, T.N., Varlamov, A.V., Anikina, L.V., Obydennik, A.Y., Nevskaya, E.Y., Niso, M., Colabufo, N.A., and Carrieri, A. (2024). Nature-inspired 1-phenylpyrrolo[2,1-a]isoquinoline scaffold for novel antiproliferative agents circumventing P-glycoprotein-dependent multidrug resistance. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202403.0491.v1"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1039\/D1RA06981K","article-title":"The synthesis of anticancer sulfonated indolo[2,1-a]isoquinoline and benzimidazo[2,1-a]isoquinolin-6(5H)-ones derivatives via a free radical cascade pathway","volume":"12","author":"Pan","year":"2022","journal-title":"RSC Adv."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"133153","DOI":"10.1016\/j.molstruc.2022.133153","article-title":"Novel indolo[3,2-c]isoquinoline-5-one-6-yl[1,2,4]triazolo [3,4-b][1,3,4]thiadiazole analogues: Design, synthesis, anticancer activity, docking with SARS-CoV-2 omicron protease and MESP\/TD-DFT approaches","volume":"1264","author":"Verma","year":"2022","journal-title":"J. Mol. Struct."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1021\/acsomega.1c06994","article-title":"Nitrophenyl-group-containing heterocycles. I. Synthesis, characterization, crystal structure, anticancer activity, and antioxidant properties of some new 5,6,7,8-tetrahydroisoquinolines bearing 3(4)-nitrophenyl group","volume":"7","author":"Sayed","year":"2022","journal-title":"ACS Omega"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ddr.22054","article-title":"Thieno [2,3-c]isoquinolines: A novel chemotype of antiproliferative agents inducing cellular apoptosis while targeting the G2\/M phase and tubulin","volume":"84","author":"Marae","year":"2023","journal-title":"Drug Dev. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/jphp.12467","article-title":"Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo","volume":"67","author":"Zheng","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/jphp.13159","article-title":"TNBG-5602, a novel derivative of quinoxaline, inhibits liver cancer growth via upregulating peroxisome proliferator-activated receptor \u03b3 in vitro and in vivo","volume":"71","author":"Hu","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"26528","DOI":"10.1039\/C8RA04152K","article-title":"Synthesis and evaluation of new sterol derivatives as potential antitumor agents","volume":"8","author":"Chen","year":"2018","journal-title":"RSC Adv."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/acs.jmedchem.0c01512","article-title":"Tetrazanbigen derivatives as peroxisome proliferator-activated receptor gamma (PPAR\u03b3) partial agonists:\u2009Design, synthesis, structure-activity relationship, and anticancer activities","volume":"64","author":"Gan","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/CAD.0000000000001077","article-title":"LFZ-4-46, a tetrahydroisoquinoline derivative, induces apoptosis and cell cycle arrest via induction of DNA damage and activation of MAPKs pathway in cancer cells","volume":"32","author":"Xu","year":"2021","journal-title":"Anti-Cancer Drugs"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s41061-024-00468-7","article-title":"Significance of chalcone scaffolds in medicinal chemistry","volume":"382","author":"Mazumder","year":"2024","journal-title":"Top. Curr. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1871520620666200705215722","article-title":"Anticancer active heterocyclic chalcones: Recent developments","volume":"21","author":"Dandawate","year":"2021","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Leite, F.F., de Sousa, N.F., de Oliveira, B.H.M., Duarte, G.D., Ferreira, M.D.L., Scotti, M.T., Filho, J.M.B., Rodrigues, L.C., de Moura, R.O., and Mendon\u00e7a-Junior, F.J.B. (2023). Anticancer activity of chalcones and its derivatives: Review and in silico studies. Molecules, 28.","DOI":"10.3390\/molecules28104009"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Toublet, F.X., Laurent, A., and Pouget, C. (2025). A review of natural and synthetic chalcones as anticancer agents targeting topoisomerase enzymes. Molecules, 30.","DOI":"10.3390\/molecules30122498"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e70001","DOI":"10.1002\/cbf.70001","article-title":"Uncovering the potential of chalcone-sulfonamide hybrids: A systematic review on their anticancer activity and mechanisms of action","volume":"42","author":"Souza","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00210-022-02269-5","article-title":"[1,2,4] Triazolo [3,4-a]isoquinoline chalcone derivative exhibits anticancer activity via induction of oxidative stress, DNA damage, and apoptosis in Ehrlich solid carcinoma-bearing mice","volume":"395","author":"WalyEldeen","year":"2022","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"26647","DOI":"10.1038\/s41598-024-76459-x","article-title":"Design, in silico studies and biological evaluation of novel chalcones tethered triazolo[3,4-a]isoquinoline as EGFR inhibitors targeting resistance in non-small cell lung cancer","volume":"14","author":"Abdelaal","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Darwish, M.I.M., Moustafa, A.M., Youssef, A.M., Mansour, M., Yousef, A.I., El Omri, A., Shawki, H.H., Mohamed, M.F., Hassaneen, H.M., and Abdelhamid, I.A. (2023). Novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones suppress breast carcinoma through cell cycle arrests and apoptosis. Molecules, 28.","DOI":"10.3390\/molecules28083338"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/1871520619666191024121116","article-title":"Molecular docking study, cytotoxicity, cell cycle arrest and apoptotic induction of novel chalcones incorporating thiadiazolyl isoquinoline in cervical cancer","volume":"20","author":"Tantawy","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Teleb, M.A.M., Kamel, M.G., Mikhail, M.S., Hassaneen, H.M., Erian, A.W., and Helmy, M.T. (2025). Synthesis, reactions, antitumor and antimicrobial activity of new 5,6-dihydropyrrolo[2,1-a]isoquinoline chalcones. BMC Chem., 19.","DOI":"10.1186\/s13065-025-01557-4"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10637-023-01382-3","article-title":"Pharmacological assessment of the antineoplastic and immunomodulatory properties of a new spiroindolone derivative (7\u2032,8\u2032-dimethoxy-1\u2032,3\u2032-dimethyl-1,2,3\u2032,4\u2032-tetrahydrospiro[indole-3,5\u2032-pyrazolo [3,4-c]isoquinolin]-2-one) in chronic myeloid leukemia","volume":"41","author":"Bogza","year":"2023","journal-title":"Investig. New Drugs"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Haque, A., Alenezi, K.M., Al-Otaibi, A., Alsukaibi, A.K.D., Rahman, A., Hsieh, M.F., Tseng, M.W., and Wong, W.Y. (2024). Synthesis, characterization, cytotoxicity, cellular imaging, molecular docking, and ADMET studies of piperazine-linked 1,8-naphthalimide-arylsulfonyl derivatives. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021069"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ruan, W., Xie, Z., Wang, Y., Xia, L., Guo, Y., and Qiao, D. (2024). An overview of naphthylimide as specific scaffold for new drug discovery. Molecules, 29.","DOI":"10.3390\/molecules29194529"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"105677","DOI":"10.1016\/j.bioorg.2022.105677","article-title":"Recent developments on 1,8-naphthalimide moiety as potential target for anticancer agents","volume":"121","author":"Tandon","year":"2022","journal-title":"Bioorganic Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.1021\/acs.inorgchem.2c01005","article-title":"Design, synthesis, and anticancer studies of a p-cymene-Ru(II)-curcumin organometallic conjugate based on a fluorescent 4-amino-1,8-naphthalimide Tr\u00f6ger\u2019s base scaffold","volume":"61","author":"Mohan","year":"2022","journal-title":"Inorg. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Rykowski, S., Gurda-Wo\u017ana, D., Orlicka-P\u0142ocka, M., Fedoruk-Wyszomirska, A., Giel-Pietraszuk, M., Wyszko, E., Kowalczyk, A., St\u0105czek, P., Biniek-Antosiak, K., and Rypniewski, W. (2022). Design of DNA intercalators based on 4-carboranyl-1,8-naphthalimides: Investigation of their DNA-binding ability and anticancer activity. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094598"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"103432","DOI":"10.1016\/j.bioorg.2019.103432","article-title":"Synthesis of naphthalimide-carborane and metallacarborane conjugates: Anticancer activity, DNA binding ability","volume":"94","author":"Nekvinda","year":"2020","journal-title":"Bioorganic Chem."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Rykowski, S., Gurda-Wo\u017ana, D., Orlicka-P\u0142ocka, M., Fedoruk-Wyszomirska, A., Giel-Pietraszuk, M., Wyszko, E., Kowalczyk, A., St\u0105czek, P., Bak, A., and Kiliszek, A. (2021). Design, synthesis, and evaluation of novel 3-carboranyl-1,8-naphthalimide derivatives as potential anticancer agents. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052772"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/cmdc.202100034","article-title":"Synthesis of triphenylethylene-naphthalimide conjugates as topoisomerase-II\u03b1 inhibitor and HSA binder","volume":"16","author":"Rani","year":"2021","journal-title":"ChemMedChem"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"112721","DOI":"10.1016\/j.jinorgbio.2024.112721","article-title":"A series of DNA targeted Cu(II) complexes containing 1,8-naphthalimide ligands: Synthesis, characterization and in vitro anticancer activity","volume":"261","author":"Wang","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s11033-019-05239-y","article-title":"Synthesis of naphthalimide derivatives with potential anticancer activity, their comparative ds- and G-quadruplex-DNA binding studies and related biological activities","volume":"47","author":"Yildiz","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"120651","DOI":"10.1016\/j.lfs.2022.120651","article-title":"Design, synthesis and bioactivity of novel naphthalimide-benzotriazole conjugates against A549 cells via targeting BCL2 G-quadruplex and inducing autophagy","volume":"302","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e202401873","DOI":"10.1002\/cbdv.202401873","article-title":"Design, synthesis, and biological evaluation of naphthalimide-polyamine conjugate as a potential anti-colorectal cancer agent","volume":"22","author":"Dai","year":"2025","journal-title":"Chem. Biodivers."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"111425","DOI":"10.1016\/j.jinorgbio.2021.111425","article-title":"Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives","volume":"219","author":"Fan","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1515\/hsz-2021-0388","article-title":"Characterization of a fluorescent 1,8-naphthalimide-functionalized PAMAM dendrimer and its Cu(II) complexes as cytotoxic drugs: EPR and biological studies in myeloid tumor cells","volume":"403","author":"Canonico","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"104011","DOI":"10.1016\/j.bioorg.2020.104011","article-title":"A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance","volume":"101","author":"Li","year":"2020","journal-title":"Bioorganic Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1002\/asia.202100926","article-title":"A novel fluorescence probe for the reversible detection of bisulfite and hydrogen peroxide pair in vitro and in vivo","volume":"16","author":"Wang","year":"2021","journal-title":"Chem. Asian J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1039\/D4CC02882A","article-title":"A naphthalimide-based fluorescent platform for endoplasmic reticulum targeted imaging","volume":"60","author":"Li","year":"2024","journal-title":"Chem. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Li, Y., Cai, Z., Gu, J., Chen, J., and Zhang, Y. (2024). Naphthalimide-based functional glycopolymeric nanoparticles as fluorescent probes for selective imaging of tumor cells. Chemistry, 30.","DOI":"10.1002\/chem.202304165"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"108013","DOI":"10.1016\/j.bioorg.2024.108013","article-title":"Rational design and syntheses of naphthalimide-based fluorescent probes for targeted detection of diabetes biomarkers","volume":"154","author":"Roy","year":"2025","journal-title":"Bioorganic Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2469493","DOI":"10.1080\/14686996.2025.2469493","article-title":"Naphthalimide-based fluorescent polymeric probe: A dual-phase sensor for formaldehyde detection","volume":"26","author":"Roy","year":"2025","journal-title":"Sci. Technol. Adv. Mater."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"106969","DOI":"10.1016\/j.bioorg.2023.106969","article-title":"Nucleolus imaging based on naphthalimide derivatives","volume":"142","author":"Yang","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Jama-Kmiecik, A., M\u0105czy\u0144ska, B., Frej-M\u0105drzak, M., Choroszy-Kr\u00f3l, I., Dudek-Wicher, R., Pi\u0105tek, D., Kujawa, K., and Sarowska, J. (2025). The changes in the antibiotic resistance of Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis and Enterococcus faecium in the clinical isolates of a multiprofile hospital over 6 years (2017\u20132022). J. Clin. Med., 14.","DOI":"10.3390\/jcm14020332"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Karanja, C.W., Naganna, N., Abutaleb, N.S., Dayal, N., Onyedibe, K.I., Aryal, U., Seleem, M.N., and Sintim, H.O. (2022). Isoquinoline antimicrobial agent: Activity against intracellular bacteria and effect on global bacterial proteome. Molecules, 27.","DOI":"10.3390\/molecules27165085"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41557-024-01516-x","article-title":"Discovery of isoquinoline sulfonamides as allosteric gyrase inhibitors with activity against fluoroquinolone-resistant bacteria","volume":"16","author":"Bakker","year":"2024","journal-title":"Nat. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e22783","DOI":"10.1016\/j.heliyon.2023.e22783","article-title":"Comparative study of antioxidant and antimicrobial activity of berberine-derived Schiff bases, nitro-berberine and amino-berberine","volume":"9","author":"Bagherzade","year":"2023","journal-title":"Heliyon"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"116648","DOI":"10.1016\/j.bmc.2022.116648","article-title":"Synthesis and biological evaluation of tetrahydroisoquinoline-derived antibacterial compounds","volume":"57","author":"Payne","year":"2022","journal-title":"Bioorganic Med. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"129829","DOI":"10.1016\/j.molstruc.2020.129829","article-title":"Synthesis of novel indolo[3,2-c]isoquinoline derivatives bearing pyrimidine, piperazine rings and their biological evaluation and docking studies against COVID-19 virus main protease","volume":"1229","author":"Verma","year":"2021","journal-title":"J. Mol. Struct."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Hatiya, M., Merid, Y., Mola, A., Belayneh, F., and Ali, M.M. (2025). Prevalence of drug-resistant Mycobacterium tuberculosis and its associated factors among tuberculosis patients attending Dilla university referral hospital, Ethiopia. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-11191-z"},{"key":"ref_148","first-page":"100295","article-title":"Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities","volume":"7","author":"Chin","year":"2024","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/cid\/ciz914","article-title":"Bedaquiline for the treatment of multidrug-resistant tuberculosis in the United States","volume":"71","author":"Mase","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Elbehiry, A., Marzouk, E., Edrees, H.M., AlShaqi, R., Ellethy, A.T., Alzaben, F., Anagreyyah, S., Algarni, A., Almuhaydili, K., and Alotaibi, I. (2025). Advancing the fight against tuberculosis: Integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1596579"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"105507","DOI":"10.1016\/j.micpath.2022.105507","article-title":"Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action","volume":"165","author":"Liu","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e202200939","DOI":"10.1002\/cbdv.202200939","article-title":"Design, synthesis, and antimycobacterial evaluation of novel tetrahydroisoquinoline hydrazide analogs","volume":"20","author":"Kumar","year":"2023","journal-title":"Chem. Biodivers."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Habschied, K., Krstanovi\u0107, V., Zduni\u0107, Z., Babi\u0107, J., Mastanjevi\u0107, K., and \u0160ari\u0107, G.K. (2021). Mycotoxins biocontrol methods for healthier crops and stored products. J. Fungi, 7.","DOI":"10.3390\/jof7050348"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Latiffah, Z. (2024). An overview of Aspergillus species associated with plant diseases. Pathogens, 13.","DOI":"10.3390\/pathogens13090813"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Al-Shaarani, A.A.Q.A., and Pecoraro, L. (2024). A review of pathogenic airborne fungi and bacteria: Unveiling occurrence, sources, and profound human health implication. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1428415"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11030-022-10463-z","article-title":"Design, synthesis and mechanism study of novel natural-derived isoquinoline derivatives as antifungal agents","volume":"27","author":"Chen","year":"2023","journal-title":"Mol. Divers."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e202300905","DOI":"10.1002\/cbdv.202300905","article-title":"N-sulfonyl-1,2,3,4-tetrahydroisoquinoline derivatives: Synthesis, antimicrobial evaluations, and theoretical insights","volume":"20","author":"Palermo","year":"2023","journal-title":"Chem. Biodivers."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"106598","DOI":"10.1016\/j.bioorg.2023.106598","article-title":"Exploration of indolo [3,2c]isoquinoline derived triazoles as potential antimicrobial and DNA cleavage agents: Synthesis, DFT calculations, and molecular modeling studies","volume":"137","author":"Basavarajaiah","year":"2023","journal-title":"Bioorganic Chem."},{"key":"ref_159","first-page":"19S","article-title":"Hepatitis B: Screening, awareness, and the need to treat","volume":"33","author":"Lingala","year":"2016","journal-title":"Fed. Pract."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S2468-1253(25)00189-X","article-title":"Estimating the annual number of hepatitis C virus infections through vertical transmission at country, regional, and global levels: A data synthesis study","volume":"10","author":"Trickey","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_161","first-page":"e38678","article-title":"Double trouble co-infections: Understanding the correlation between COVID-19 and HIV viruses","volume":"15","author":"Abbasi","year":"2023","journal-title":"Cureus"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2021.02.001","article-title":"Is COVID-19 the worst pandemic?","volume":"149","author":"Feehan","year":"2021","journal-title":"Maturitas"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"106549","DOI":"10.1016\/j.bioorg.2023.106549","article-title":"Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities","volume":"136","author":"Hu","year":"2023","journal-title":"Bioorganic Chem."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Shad, M.S., Claes, S., Goffin, E., Van Loy, T., Schols, D., De Jonghe, S., and Dehaen, W. (2021). Synthesis and anti-HIV activity of a novel series of isoquinoline-based CXCR4 antagonists. Molecules, 26.","DOI":"10.3390\/molecules26206297"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Ye, J., and Chen, J. (2021). Interferon and hepatitis B: Current and future perspectives. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.733364"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1478-3231.2010.02384.x","article-title":"Chronic hepatitis B: Peginterferon or nucleos(t)ide analogues?","volume":"31","author":"Sonneveld","year":"2011","journal-title":"Liver Int."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1021\/acs.jmedchem.4c01568","article-title":"Rational design, synthesis, and structure\u2013activity relationship of a novel isoquinolinone-based series of HBV capsid assembly modulators leading to the identification of clinical candidate AB-836","volume":"67","author":"Cole","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"105252","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antivir. Res."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Soares, V.C., Moreira, I.B.G., and Dias, S.S.G. (2025). SARS-CoV-2 infection and antiviral strategies: Advances and limitations. Viruses, 17.","DOI":"10.3390\/v17081064"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Tian, L., Pang, Z., Li, M., Lou, F., An, X., Zhu, S., Song, L., Tong, Y., Fan, H., and Fan, J. (2022). Molnupiravir and its antiviral activity against COVID-19. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.855496"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1093\/cid\/ciac443","article-title":"Effectiveness of Paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients","volume":"76","author":"Gronich","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Wang, X., Burdzhiev, N.T., Hu, H., Li, Y., Li, J., Lozanova, V.V., Kandinska, M.I., and Wang, M. (2023). Novel tetrahydroisoquinoline-based heterocyclic compounds efficiently inhibit SARS-CoV-2 infection in vitro. Viruses, 15.","DOI":"10.3390\/v15020502"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Kandinska, M.I., Burdzhiev, N.T., Cheshmedzhieva, D.V., Ilieva, S.V., Grozdanov, P.P., Vilhelmova-Ilieva, N., Nikolova, N., Lozanova, V.V., and Nikolova, I. (2023). Synthesis of novel 1-oxo-2,3,4-trisubstituted tetrahydroisoquinoline derivatives, bearing other heterocyclic moieties and comparative preliminary study of anti-coronavirus activity of selected compounds. Molecules, 28.","DOI":"10.3390\/molecules28031495"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s11696-018-00677-7","article-title":"Synthesis of novel trans-4-(phthalimidomethyl)- and 4-(imidazol-1-ylmethyl)-3-indolyl-tetrahydroisoquinolinones as possible aromatase inhibitors","volume":"73","author":"Burdzhiev","year":"2019","journal-title":"Chem. Pap."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1021\/acs.jmedchem.5c00042","article-title":"Design and synthesis of PAN endonuclease inhibitors through spirocyclization strategy against influenza A virus","volume":"68","author":"Liu","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"112048","DOI":"10.1016\/j.ejmech.2020.112048","article-title":"Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease","volume":"189","author":"Liao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"113929","DOI":"10.1016\/j.ejmech.2021.113929","article-title":"Discovery and optimization of new 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors","volume":"227","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/apjtm.apjtm_932_23","article-title":"Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections","volume":"17","author":"Khan","year":"2024","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"114608","DOI":"10.1016\/j.ejmech.2022.114608","article-title":"Discovery of potent Ebola entry inhibitors with (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl) decahydroisoquinoline-3-carboxamide scaffold","volume":"240","author":"Han","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"130230","DOI":"10.1016\/j.bmcl.2025.130230","article-title":"Discovery of novel Ebola entry inhibitors with 1,2,3,4-tetrahydroisoquinoline-3-carboxamide based on (3S,4aS,8aS)-2-(3-amino-2-hydroxypropyl)decahydroisoquinoline-3-carboxamide scaffold","volume":"123","author":"Lin","year":"2025","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Dahalan, F.A., Churcher, T.S., Windbichler, N., and Lawniczak, M.K.N. (2019). The male mosquito contribution towards malaria transmission: Mating influences the Anopheles female midgut transcriptome and increases female susceptibility to human malaria parasites. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008063"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Savi, M.K. (2022). An overview of malaria transmission mechanisms, control, and modeling. Med. Sci., 11.","DOI":"10.20944\/preprints202212.0077.v1"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(23)01249-7","article-title":"Malaria","volume":"402","author":"Poespoprodjo","year":"2023","journal-title":"Lancet"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00044-020-02642-0","article-title":"Synthesis, characterization and antimalarial activity of isoquinoline derivatives","volume":"30","author":"Theeramunkong","year":"2021","journal-title":"Med. Chem. Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/14756366.2019.1706502","article-title":"Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives","volume":"35","author":"Guillon","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"17932","DOI":"10.1038\/s41598-020-74824-0","article-title":"Spirofused tetrahydroisoquinoline-oxindole hybrids as a novel class of fast acting antimalarial agents with multiple modes of action","volume":"10","author":"Efange","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"191316","DOI":"10.1098\/rsos.191316","article-title":"3\u2032,4\u2032-Dihydro-2\u2032H-spiro[indoline-3,1\u2032-isoquinolin]-2-ones as potential anti-cancer agents: Synthesis and preliminary screening","volume":"7","author":"Lobe","year":"2020","journal-title":"R. Soc. Open Sci."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e0060722","DOI":"10.1128\/aac.00607-22","article-title":"Spirofused tetrahydroisoquinoline-oxindole hybrids (Spiroquindolones) as potential multitarget antimalarial agents: Preliminary hit optimization and efficacy evaluation in mice","volume":"66","author":"Efange","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Papagni, R., Novara, R., Minardi, M.L., Frallonardo, L., Panico, G.G., Pallara, E., Cotugno, S., Ascoli Bartoli, T., Guido, G., and DeVita, E. (2023). Human African Trypanosomiasis (sleeping sickness): Currentknowledge and future challenges. Front. Trop. Dis., 4.","DOI":"10.3389\/fitd.2023.1087003"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"158","DOI":"10.15585\/mmwr.mm7409a3","article-title":"Notes from the field: Rhodesiense Human African Trypanosomiasis (sleeping sickness) in a traveler returning from Zimbabwe\u2014United States, August 2024","volume":"74","author":"Wendt","year":"2025","journal-title":"MMWR\u2013Morb. Mortal. Wkly. Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"113861","DOI":"10.1016\/j.ejmech.2021.113861","article-title":"Synthesis and evaluation of tetrahydroisoquinoline derivatives against Trypanosoma brucei rhodesiense","volume":"226","author":"Cullen","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14787210.2024.2438627","article-title":"Anti-leishmanial therapies: Overcoming current challenges with emerging therapies","volume":"23","author":"Sundar","year":"2025","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkaf059","article-title":"Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia\u2014Authors\u2019 response","volume":"80","author":"Dorlo","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/13543784.2024.2400139","article-title":"Investigational new drugs for the treatment of leishmaniasis","volume":"33","author":"Sundar","year":"2024","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1051\/parasite\/2025009","article-title":"Leishmaniases: Strategies in treatment development","volume":"32","author":"Majoor","year":"2025","journal-title":"Parasite"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1021\/acs.joc.9b01357","article-title":"Carbopalladation\/Suzuki coupling cascade for the generation of quaternary centers: Access to pyrrolo[1,2-b]isoquinolines","volume":"84","author":"Barbolla","year":"2019","journal-title":"J. Org. Chem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"113458","DOI":"10.1016\/j.ejmech.2021.113458","article-title":"Palladium-mediated synthesis and biological evaluation of C-10b substituted dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents","volume":"220","author":"Barbolla","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e202300154","DOI":"10.1002\/cmdc.202300154","article-title":"Praziquantel\u201450 years of research","volume":"18","author":"Waechtler","year":"2023","journal-title":"ChemMedChem"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"e02582-16","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Kasago, F.M., H\u00e4berli, C., Keiser, J., and Masamba, W. (2023). Design, synthesis and evaluation of praziquantel analogues and new molecular hybrids as potential antimalarial and anti-schistosomal agents. Molecules, 28.","DOI":"10.3390\/molecules28135184"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"103722","DOI":"10.1016\/j.bioorg.2020.103722","article-title":"Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and A\u03b21-42 aggregation","volume":"98","author":"Plazas","year":"2020","journal-title":"Bioorganic Chem."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Cahl\u00edkov\u00e1, L., Vrabec, R., Pidan\u00fd, F., Pe\u0159inov\u00e1, R., Maafi, N., Mamun, A.A., Ritomsk\u00e1, A., Wijaya, V., and Blunden, G. (2021). Recent progress on biological activity of amaryllidaceae and further isoquinoline alkaloids in connection with Alzheimer\u2019s disease. Molecules, 26.","DOI":"10.3390\/molecules26175240"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2025914","DOI":"10.1155\/2018\/2025914","article-title":"The isoquinoline alkaloid dauricine targets multiple molecular pathways to ameliorate Alzheimer-like pathological changes in vitro","volume":"2018","author":"Liu","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"106126","DOI":"10.1016\/j.phrs.2022.106126","article-title":"Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases","volume":"177","author":"Plazas","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Li, J., Wu, Y., Dong, S., Yu, Y., Wu, Y., Xiang, B., and Li, Q. (2023). Research progress on neuroprotective effects of isoquinoline alkaloids. Molecules, 28.","DOI":"10.3390\/molecules28124797"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ddr.21631","article-title":"Dual targeting of cholinesterase and amyloid beta with pyridinium\/isoquinolium derivatives","volume":"81","author":"Chakravarty","year":"2020","journal-title":"Drug Dev. Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"137166","DOI":"10.1016\/j.neulet.2023.137166","article-title":"Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"802","author":"Wei","year":"2023","journal-title":"Neurosci. Lett."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1021\/acschemneuro.0c00464","article-title":"An isoquinolinium dual inhibitor of cholinesterases and amyloid \u03b2 aggregation mitigates neuropathological changes in a triple-transgenic mouse model of Alzheimer\u2019s disease","volume":"11","author":"Ju","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"106847","DOI":"10.1016\/j.phrs.2023.106847","article-title":"Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States","volume":"194","author":"Roskoski","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40263-024-01070-7","article-title":"SAFE-ROCK: A phase I trial of an oral application of the ROCK inhibitor fasudil to assess bioavailability, safety, and tolerability in healthy participants","volume":"38","author":"Wolff","year":"2024","journal-title":"CNS Drugs"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"115524","DOI":"10.1016\/j.bbr.2025.115524","article-title":"Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease","volume":"484","author":"Sulaiman","year":"2025","journal-title":"Behav. Brain Res."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/0115672050317608240531130204","article-title":"ROCK inhibitor fasudil attenuates neuroinflammation and associated metabolic dysregulation in the tau transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Ouyang","year":"2024","journal-title":"Curr. Alzheimer Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00775-023-02013-1","article-title":"Sulfur-bridging the gap: Investigating the electrochemistry of novel copper chelating agents for Alzheimer\u2019s disease applications","volume":"28","author":"Crnich","year":"2023","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41551-021-00819-5","article-title":"Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow","volume":"6","author":"Xie","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7150\/thno.88718","article-title":"Selective induction of Rab9-dependent alternative mitophagy using a synthetic derivative of isoquinoline alleviates mitochondrial dysfunction and cognitive deficits in Alzheimer\u2019s disease models","volume":"14","author":"Um","year":"2024","journal-title":"Theranostics"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.7150\/thno.105953","article-title":"Pharmacological targeting of mitophagy via ALT001 improves herpes simplex virus 1 (HSV1)-mediated microglial inflammation and promotes amyloid \u03b2 phagocytosis by restricting HSV1 infection","volume":"15","author":"Oh","year":"2025","journal-title":"Theranostics"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/gerona\/glad169","article-title":"3-[[(3S)-1,2,3,4-Tetrahydroisoquinoline-3-carbonyl]amino]propanoic acid (THICAPA) is protective against A\u03b242-induced toxicity in vitro and in an Alzheimer\u2019s disease drosophila","volume":"78","author":"Tan","year":"2023","journal-title":"J. Gerontol. Ser. A"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e30788","DOI":"10.1016\/j.heliyon.2024.e30788","article-title":"A comprehensive review on the progress and challenges of tetrahydroisoquinoline derivatives as a promising therapeutic agent to treat Alzheimer\u2019s disease","volume":"10","author":"Thangeswaran","year":"2024","journal-title":"Heliyon"},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Nevskaya, A.A., Anikina, L.V., Purgatorio, R., Catto, M., Nicolotti, O., de Candia, M., Pisani, L., Borisova, T.N., Miftyakhova, A.R., and Varlamov, A.V. (2021). Homobivalent lamellarin-like Schiff bases: In vitro evaluation of their cancer cell cytotoxicity and multitargeting anti-Alzheimer\u2019s disease potential. Molecules, 26.","DOI":"10.3390\/molecules26020359"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/acs.jcim.8b00698","article-title":"A new approach for drug target and bioactivity prediction: The multifingerprint similarity search algorithm (MuSSeL)","volume":"59","author":"Alberga","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/ptr.7833","article-title":"Dual action anti-inflammatory\/antiviral isoquinoline alkaloids as potent naturally occurring anti-SARS-CoV-2 agents: A combined pharmacological and medicinal chemistry perspective","volume":"37","author":"Valipour","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Zhu, C., Li, K., Peng, X.X., Yao, T.J., Wang, Z.Y., Hu, P., Cai, D., and Liu, H.Y. (2022). Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1083788"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10822-025-00628-x","article-title":"Anti-inflammatory potential of isoquinoline alkaloids from Fumaria officinalis: In vitro, in vivo, and in silico evaluation","volume":"39","author":"Yahiaoui","year":"2025","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/a-2369-8104","article-title":"Anti-inflammatory principles of the plant family Amaryllidaceae","volume":"90","author":"Nair","year":"2024","journal-title":"Planta Medica"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"113811","DOI":"10.1016\/j.jep.2021.113811","article-title":"Diverse isoquinolines with anti-inflammatory and analgesic bioactivities from Hypecoum erectum","volume":"270","author":"Yuan","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/14786419.2020.1795855","article-title":"A novel alkaloid from Portulaca oleracea L. and its anti-inflammatory activity","volume":"36","author":"Gu","year":"2022","journal-title":"Nat. Prod. Res."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"e13729","DOI":"10.1111\/crj.13729","article-title":"Anti-inflammatory effects of reticuline on the JAK2\/STAT3\/SOCS3 and p38 MAPK\/NF-\u03baB signaling pathway in a mouse model of obesity-associated asthma","volume":"18","author":"Lyu","year":"2024","journal-title":"Clin. Respir. J."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Kem, W.R., Soti, F., Rocca, J.R., and Johnson, J.V. (2024). New pyridyl and dihydroisoquinoline alkaloids isolated from the Chevron Nemertean Amphiporus angulatus. Mar. Drugs, 22.","DOI":"10.3390\/md22040141"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Cui, L., Peng, C., Li, J., Cheng, X., Fan, X., Li, J., Yang, Z., Zhao, Y., and Ma, Y. (2023). The anti-inflammatory and analgesic activities of 2Br-crebanine and stephanine from Stephania yunnanenses H. S.Lo. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1092583"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: Important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jdv.18818","article-title":"Pharmacology of orismilast, a potent and selective PDE4 inhibitor","volume":"37","author":"Silverberg","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2174\/0929867324666170530093902","article-title":"Phosphodiesterase 4 inhibitors in immune-mediated diseases: Mode of action, clinical applications, current and future perspectives","volume":"24","author":"Sakkas","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/bph.14667","article-title":"Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"105265","DOI":"10.1016\/j.bioorg.2021.105265","article-title":"CuCl2-catalyzed inexpensive, faster and ligand\/additive free synthesis of isoquinolin-1(2H)-one derivatives via the coupling-cyclization strategy: Evaluation of a new class of compounds as potential PDE4 inhibitors","volume":"115","author":"Thirupataiah","year":"2021","journal-title":"Bioorganic Chem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"115412","DOI":"10.1016\/j.ejmech.2023.115412","article-title":"Anti-inflammatory efficacy and relevant SAR investigations of novel chiral pyrazolo isoquinoline derivatives: Design, synthesis, in-vitro, in-vivo, and computational studies targeting iNOS","volume":"256","author":"Akhtar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/acs.jmedchem.9b00518","article-title":"Structure-aided identification and optimization of tetrahydro-isoquinolines as novel PDE4 inhibitors leading to discovery of an effective antipsoriasis agent","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"113958","DOI":"10.1016\/j.bcp.2020.113958","article-title":"DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling","volume":"177","author":"Li","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"105685","DOI":"10.1016\/j.jbspin.2023.105685","article-title":"NSAID: Current limits to prescription","volume":"91","author":"Wirth","year":"2024","journal-title":"Jt. Bone Spine"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"117899","DOI":"10.1016\/j.bmc.2024.117899","article-title":"Design, classification, and adverse effects of NSAIDs: A review on recent advancements","volume":"112","author":"Arfeen","year":"2024","journal-title":"Bioorganic Med. Chem."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7861\/clinmed.2021-0039","article-title":"Non-steroidal anti-inflammatory drugs and the gastrointestinal tract","volume":"21","author":"Tai","year":"2021","journal-title":"Clin. Med."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"107577","DOI":"10.1016\/j.bioorg.2024.107577","article-title":"Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1\/2-inhibitors","volume":"150","author":"Hassan","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"115734","DOI":"10.1016\/j.biopha.2023.115734","article-title":"Diabetes mellitus: Classification, mediators, and complications; a gate to identify potential targets for the development of new effective treatments","volume":"168","author":"Antar","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1021\/acsmedchemlett.2c00220","article-title":"Novel 6-methoxy-3,4-dihydro-1H-isoquinoline compounds for treating diabetes","volume":"13","author":"Sabnis","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_248","unstructured":"Eli Lilly and Company (2022). 6-Methoxy-3,4-dihydro-1H-isoquinoline Compounds Useful in the Treatment of Diabetes. (International Application No. PCT\/US2021\/053691)."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Skoczy\u0144ska, A., O\u0142dakowska, M., Dobosz, A., Adamiec, R., Gritskevich, S., Jonkisz, A., Lebioda, A., Adamiec-Mroczek, J., Ma\u0142odobra-Mazur, M., and Dobosz, T. (2024). PPARs in clinical experimental medicine after 35 years of worldwide scientific investigations and medical experiments. Biomolecules, 14.","DOI":"10.3390\/biom14070786"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"118264","DOI":"10.1016\/j.ejmech.2025.118264","article-title":"Structural and Functional Insights into PPAR-\u03b3: Review of its potential and drug design innovations for the development of antidiabetic agents","volume":"302","author":"Gupta","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"978687","DOI":"10.1155\/2012\/978687","article-title":"Idealized PPAR\u03b3-based therapies: Lessons from bench and bedside","volume":"2012","author":"Amato","year":"2012","journal-title":"PPAR Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1248\/cpb.c20-00841","article-title":"Synthesis and evaluation of a novel series of 2,7-substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives as selective peroxisome proliferator-activated receptor \u03b3 partial agonists","volume":"69","author":"Morishita","year":"2021","journal-title":"Chem. Pharm. Bull."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1248\/cpb.c19-00541","article-title":"(S)-1,2,3,4-Tetrahydroisoquinoline derivatives substituted with an acidic group at the 6-position as a selective peroxisome proliferator-activated receptor \u03b3 partial agonist","volume":"67","author":"Morishita","year":"2019","journal-title":"Chem. Pharm. Bull."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.apsb.2024.01.018","article-title":"Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms","volume":"14","author":"Sun","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1039\/D2MD00376G","article-title":"Natural-product-based fluorescent probes: Recent advances and applications","volume":"14","author":"Sung","year":"2022","journal-title":"RSC Med. Chem."},{"key":"ref_256","first-page":"433","article-title":"PET\/SPECT molecular imaging in clinical neuroscience: Recent advances in the investigation of CNS diseases","volume":"5","author":"Lu","year":"2015","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1259\/bjr\/97295129","article-title":"Positron emission tomography imaging in dementia","volume":"80","author":"Herholz","year":"2007","journal-title":"Br. J. Radiol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00259-024-06603-2","article-title":"The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer\u2019s disease","volume":"51","author":"Colmant","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"100850","DOI":"10.1016\/j.rechem.2023.100850","article-title":"Recent advances in fluorescent-based cation sensors for biomedical applications","volume":"5","author":"Rajasekar","year":"2023","journal-title":"Results Chem."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"e70137","DOI":"10.1002\/bio.70137","article-title":"isoquinoline-fused benzimidazoles based highly selective fluorogenic receptors for detection of Cu2+, Fe3+, and Cl\u2212 ions: Cytotoxicity and HepG2 cancer cell imaging","volume":"40","author":"Murugaperumal","year":"2025","journal-title":"Luminescence"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"104021","DOI":"10.1016\/j.bioorg.2020.104021","article-title":"Synthesis of a novel fluorescent berberine derivative convenient for its subcellular localization study","volume":"101","author":"Jin","year":"2020","journal-title":"Bioorganic Chem."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"116211","DOI":"10.1016\/j.biopha.2024.116211","article-title":"A review on metal complexes and its anticancer activities: Recent updates from in vivo studies","volume":"171","author":"Adhikari","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal complexes in cancer therapy\u2014An up-date from drug design perspective","volume":"11","author":"Ndagi","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"13719","DOI":"10.1021\/acs.jmedchem.0c01277","article-title":"Cancer cell resistance against the clinically investigated thiosemicarbazone COTI-2 is based on formation of intracellular copper complex glutathione adducts and ABCC1-mediated efflux","volume":"63","author":"Hager","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Gaber, A., Alsanie, W.F., Kumar, D.N., Refat, M.S., and Saied, E.M. (2020). Novel papaverine metal complexes with potential anticancer activities. Molecules, 25.","DOI":"10.3390\/molecules25225447"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1021\/acs.jmedchem.4c00285","article-title":"Cycloplatinated (II) complex based on isoquinoline alkaloid elicits ferritinophagy-dependent ferroptosis in triple-negative breast cancer cells","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Sun, Q., Li, Y., Shi, H., Wang, Y., Zhang, J., and Zhang, Q. (2021). Ruthenium complexes as promising candidates against lung cancer. Molecules, 26.","DOI":"10.3390\/molecules26154389"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium complexes as anticancer agents: A brief history and perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"112425","DOI":"10.1016\/j.jinorgbio.2023.112425","article-title":"Ruthenium(II) polypyridyl complexes as emerging photosensitisers for antibacterial photodynamic therapy","volume":"250","author":"Ng","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1039\/D3DT00328K","article-title":"Cytotoxic cis-ruthenium(III) bis(amidine) complexes","volume":"52","author":"Liu","year":"2023","journal-title":"Dalton Trans."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1039\/D2DT00290F","article-title":"Ruthenium-nitrosyl complexes as NO-releasing molecules, potential anticancer drugs, and photoswitches based on linkage isomerism","volume":"51","author":"Stepanenko","year":"2022","journal-title":"Dalton Trans."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"105516","DOI":"10.1016\/j.bioorg.2021.105516","article-title":"Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549\/DDP cells by downregulation of Nrf2 via Akt\/GSK-3\u03b2\/Fyn pathway","volume":"119","author":"Chen","year":"2022","journal-title":"Bioorganic Chem."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"111260","DOI":"10.1016\/j.jinorgbio.2020.111260","article-title":"New copper complexes inducing bimodal death through apoptosis and autophagy in A549 cancer cells","volume":"213","author":"Gul","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Zhai, J., Gu, X., Liu, Y., Hu, Y., Jiang, Y., and Zhang, Z. (2023). Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1152934"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"111450","DOI":"10.1016\/j.jinorgbio.2021.111450","article-title":"Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis","volume":"219","author":"Chen","year":"2021","journal-title":"J. Inorg. Biochem."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1039\/C4SC02032D","article-title":"Detection of nicking endonuclease activity using a G-quadruplex-selective luminescent switch-on probe","volume":"5","author":"Lu","year":"2014","journal-title":"Chem. Sci."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.apsb.2024.06.017","article-title":"Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis","volume":"15","author":"Lu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"106837","DOI":"10.1016\/j.bioorg.2023.106837","article-title":"Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis","volume":"140","author":"Liao","year":"2023","journal-title":"Bioorganic Chem."},{"key":"ref_279","doi-asserted-by":"crossref","unstructured":"Sinicropi, M.S., Ceramella, J., Iacopetta, D., Catalano, A., Mariconda, A., Rosano, C., Saturnino, C., El-Kashef, H., and Longo, P. (2022). Metal complexes with Schiff bases: Data collection and recent studies on biological activities. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314840"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"110451","DOI":"10.1016\/j.inoche.2023.110451","article-title":"Schiff bases and their metal complexes: A review on the history, synthesis, and applications","volume":"150","author":"Boulechfar","year":"2023","journal-title":"Inorg. Chem. Commun."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"112790","DOI":"10.1016\/j.jinorgbio.2024.112790","article-title":"Schiff base-platinum and ruthenium complexes and anti-Alzheimer properties","volume":"264","author":"Yildiz","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1016\/j.jphotochemrev.2024.100652","article-title":"Molecular and nanoparticulate agents for photodynamic therapy guided by near infrared imaging","volume":"58","author":"Grebinyk","year":"2024","journal-title":"J. Photochem. Photobiol. C Photochem. Rev."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/acs.orglett.1c03804","article-title":"Direct [4 + 2] Cycloaddition to Isoquinoline-Fused Porphyrins for Near-Infrared Photodynamic Anticancer Agents","volume":"24","author":"Li","year":"2022","journal-title":"Org. Lett."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/24\/4760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:17:09Z","timestamp":1765948629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/24\/4760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":283,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["molecules30244760"],"URL":"https:\/\/doi.org\/10.3390\/molecules30244760","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}